Advanced search
Publication Cover
Cancer Investigation Volume 21, 2003 - Issue 5
Submit an article Journal homepage
40
Views
7
CrossRef citations to date
0
Altmetric
Original

Therapeutic Potential of Tyrosine Kinase Inhibitors in Breast Cancer

NEW DRUGS

Steven Averbuch AstraZeneca, Wilmington, DelawareUSA
, M.D.,,
Mana Kcenler AstraZeneca, Wilmington, DelawareUSA
, M.D.,,
Charles Morris AstraZeneca, Wilmington, DelawareUSA
, M.R.C.P., &
Alan Wakeling AstraZeneca, Alderley Park, Cheshire, UK
, Ph.D.
Pages 782-791 | Published online: 10 Aug 2003

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ladislav Novotny & Thomas Szekeres. (2005) Recent developments in cancer chemotherapy oriented towards new targets. Expert Opinion on Therapeutic Targets 9:2, pages 343-357.
Read now

Articles from other publishers (6)

Miyun Oh, Jeong-Yeon Lee, Dong-Hui Shin, Ji-Hye Park, Tingting Oian, Hyun-Jun Kim, Sung-Dae Cho, Seung-Hyun Oh, Young Ki Min & Gu Kong. (2011) The in vitro and in vivo anti-tumor effect of KO-202125, a sauristolactam derivative, as a novel epidermal growth factor receptor inhibitor in human breast cancer. Cancer Science 102:3, pages 597-604.
Crossref
Neeraj K. Saxena, LaTonia Taliaferro-Smith, Brandi B. Knight, Didier Merlin, Frank A. Anania, Ruth M. O'Regan & Dipali Sharma. (2008) Bidirectional Crosstalk between Leptin and Insulin-like Growth Factor-I Signaling Promotes Invasion and Migration of Breast Cancer Cells via Transactivation of Epidermal Growth Factor Receptor. Cancer Research 68:23, pages 9712-9722.
Crossref
Kalliopi P. Siziopikou & Melody Cobleigh. (2007) The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies. The Breast 16:1, pages 104-107.
Crossref
Kalliopi P. Siziopikou, Reshma Ariga, Kimon E. Proussaloglou, Paolo Gattuso & Melody Cobleigh. (2006) The Challenging Estrogen Receptor-Negative/ Progesterone Receptor-Negative/HER-2-Negative Patient: A Promising Candidate for Epidermal Growth Factor Receptor-Targeted Therapy?. The Breast Journal 12:4, pages 360-362.
Crossref
Karissa L. Gable, Betty A. Maddux, Cristina Penaranda, Marianna Zavodovskaya, Michael J. Campbell, Margaret Lobo, Louise Robinson, Steven Schow, John A. Kerner, Ira D. Goldfine & Jack F. Youngren. (2006) Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth. Molecular Cancer Therapeutics 5:4, pages 1079-1086.
Crossref
Jack F. Youngren, Karissa Gable, Cristina Penaranda, Betty A. Maddux, Marianna Zavodovskaya, Margaret Lobo, Michael Campbell, John Kerner & Ira D. Goldfine. (2005) Nordihydroguaiaretic Acid (NDGA) Inhibits the IGF-1 and c-erbB2/HER2/neu Receptors and Suppresses Growth in Breast Cancer Cells. Breast Cancer Research and Treatment 94:1, pages 37-46.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.